<DOC>
	<DOCNO>NCT00667407</DOCNO>
	<brief_summary>To investigate Efficacy Safety Levalbuterol versus Racemic Albuterol Treatment Acute Asthma .</brief_summary>
	<brief_title>Efficacy Safety Levalbuterol Versus Racemic Albuterol Asthma</brief_title>
	<detailed_description>This study double-blind , randomize , active-controlled , multicenter , parallel-group trial levalbuterol adult subject acute reversible airway disease . Approximately 600 subject enrol study participation consist 2 period : Period I ( Acute Period ) : Double-blind treatment Emergency Department ( ED ) Clinic disposition , maximum 24 hour double-blind treatment Period II ( Post-Acute Period ) : Subjects discharge ED Clinic continue double blind treatment ( treatment provide rescue medication MDI ) approximately 10 day . Subjects contact telephone 30 day post discharge assess relapse . This study previously post Sepracor Inc . In October 2009 , Sepracor Inc. acquire Dainippon Sumitomo Pharma. , October 2010 , Sepracor Inc 's name change Sunovion Pharmaceuticals Inc .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Male female subject must least great equal 18 year age time consent . Subjects must history asthma least 6 month . Subjects must present emergency department ( ED ) clinic force expiratory volume one second ( FEV1 ) 20 55 % ( inclusive ) predict baseline Subjects must O2 saturation great equal 90 % room air 6 Liters/minute supplemental oxygen cause wheeze shortness breath asthma determine physician . Prior use betaagonist ( e.g. , Primatine Mist , albuterol , salmeterol , etc . ) within 24 hour presentation ED Clinic . Smoked â‰¤ 10 packyears nonsmoker . Be good health exception asthma suffer chronic condition might affect lung function , COPD emphysema . Nearnormal activity level exacerbation . Subjects take inhaled systemic corticosteroid must stable dose least 21 day prior study entry . Subjects receive treatment asthma ED , Clinic , Urgent Care Center within 2 week prior study entry . Based upon history physical exam ED Clinic , subject know suspected cause pulmonary symptom asthma , COPD , CHF , pneumonia , pulmonary embolism , angioedema . Subjects history asthma episode associate hypercapnia , respiratory arrest , hypoxic seizure , require intubation within 12 month prior entry . Hospitalization asthma within two month prior entry . Female subject pregnant lactating . Subjects history clinically significant psychiatric disorder within last 3 month , exception mild depression . Subjects participate investigational drug study within 30 day study entry previously participate current trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Asthma</keyword>
</DOC>